What Happened? Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped 2.3% in the morning session after JPMorgan ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

JP Morgan recently initiated coverage on Exponent with an Overweight/Buy rating, highlighting the firm’s position as a ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (EXPO) today reported financial results for the third quarter of fiscal year 2025 ended October 3, 2025. “Exponent delivered a ...

Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter began with a historically ...

Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Fourth Quarter and fiscal year 2025 financial results for the period ended January 2, 2026 following the close of the market on ...

Engineering and scientific consulting firm Exponent Inc (NASDAQ:EXPO) shares are skyrocketing after the company reported better-than-expected first-quarter FY24 earnings. Exponent reported ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S. equity ...